A Practical Approach, Second Edition=Ronald D. Ho.pdf

ROLE OF XENOBIOTIC METABOLISM IN DEVELOPMENTAL AND REPRODUCTIVE TOXICITY 565122. Kubow, S.and Wells, P.G., In vitro bioactivation of phenytoin to a reactive free radical intermediateby prostaglandin synthase, horseradish peroxidase, and thyroid peroxidase, Mol. Pharmacol., 35, 504,1989.123. Parman, T., Chen, G., and Wells, P.G., Free radical intermediates of phenytoin and related teratogens.Prostaglandin H synthase-catalyzed bioactivation electron paramagnetic resonance spectrometry, andphotochemical product analysis, J. Biol. Chem., 273, 25079, 1998.124. Parman T., Wiley, M.J., and Wells, P.G., Free radical mediated oxidative DNA damage in the mechanismof thalidomide teratogenicity, Nature Med., 5, 582, 1999.125. Arlen, R.R. and Wells, P.G., Inhibition of thalidomide teratogenicity by acetylsalicylic acid: evidencefor prostaglandin H synthase-catalyzed bioactivation of thalidomide to a reactive intermediate, J.Pharmacol. Exp. Ther., 277, 1649, 1996.126. Vanderhoek, J.Y. and Klein, K.L., Lipoxygenases in rat embryo tissue, Proc. Soc. Exp. Biol. Med.,188, 370, 1988.127. Roy, S.K., et al., Lipoxygenase activity in rat embryo and its potential for xenobiotic oxidation, Biol.Neonate, 63, 297, 1993.128. Kubow, S. and Wells, P.G., In vitro evidence for lipoxygenase-catalyzed bioactivation of phenytoin,Pharmacologist, 30, A74, 1988.129. Yu, W.K. and Wells, P.G., Evidence for lipoxygenase-catalyzed bioactivation of phenytoin to ateratogenic reactive intermediate: in vitro studies using linoleic acid-dependent soybean lipoxygenase,and in vivo studies using pregnant CD-1 mice, Toxicol. Appl. Pharmacol., 131, 1, 1995.130. Balakier, H., Endogenous peroxidase in the visceral endoderm of early mouse embryos, J. Exp. Zool.,231, 243, 1984.131. Pelkonen, O., Environmental influences on human foetal and placental xenobiotic metabolism, Eur.J. Clin. Pharmacol., 18, 17, 1980.132. Pelkonen, O., Biotransformation of xenobiotics in the fetus, Pharmacol. Ther., 10, 261, 1980.133. Farrar, H.C. and Blumer, J.L., Fetal effects of maternal drug exposure, Ann. Rev. Pharmacol. Toxicol.,31, 525, 1991.134. Mizokami, K., et al., 3-Methylcholanthrene induces phenobarbital-induced cytochrome P450 hemoproteinin fetal liver and not cytochrome 448 hemoproteins induced in maternal liver of rats, Biochem.Biophys. Res. Commun., 107, 6, 1982.135. Kitada, M., et al., Four forms of cytochrome P450 in human fetal livers: purification and their capacityto activate promutagens, Jpn. J. Cancer Res., 82, 426, 1991.136. Rane, A. and Ackermann, E., Metabolism of ethylmorphine and aniline in human fetal liver, Clin.Pharmacol. Ther., 13, 663, 1972.137. Ladona, M.G., et al., Human fetal and adult liver metabolism of ethylmorphine, Biochem. Pharmacol.,38, 3147, 1989138. Komari, M., et al., Fetus specific expression of a form of cytochrome P450 in human livers, Biochemistry,29, 4430, 1990139. Hakkola, J., et al., Expression of xenobiotic metabolizing cytochrome P450 forms in human adultand fetal liver, Biochem. Pharmacol., 48, 59, 1994.140. Shimada, T., et al., Characterization of microsomal cytochrome P450 enzymes involved in oxidationof xenobiotic chemicals in human fetal livers and adult lungs, Drug Met. Disp., 24, 515, 1996.141. Hakkola, J., et al., Expression of CYP1B1 in human adult and fetal tissues and differential inducibilityof CYP1B1 and CYP1A1 by Ah receptor ligands in human placenta and cultured cells, Carcinogenesis,18, 391, 1997.142. Shimada, T., Misono, K.S., and Guengerich, F.P., Human liver microsomal cytochrome P450 mephenytoin4-hydroxylase, a prototype of genetic polymorphism in oxidative drug metabolism, J. Biol. Chem.,261, 909, 1986.143. Jacqz-Aigrain, E. and Cresteil, T., Cytochrome P450-dependent metabolism of dextromethorphan:fetal and adult studies, Dev. Pharmacol. Ther., 18, 161, 1992.144. Carpenter, S.J., Lasker, J.M., and Raucy, J.L., Expression, induction, and catalytic activity of theethanol-inducible cytochrome P450 (CYP2E1) in human fetal liver and hepatocytes, Mol. Pharmacol.,49, 260, 1996.145. Greuet, J., et al., The fetal specific gene CYP3A7 is inducible by rafampicin in adult hepatocytes inprimary culture, Biochem. Biophys. Res. Commun., 225, 689, 1996.© 2006 by Taylor & Francis Group, LLC